Study guide
5.3 Professional Misconduct, Discipline & Impaired Practitioner Programs
New York MPJE Pharmacy Jurisprudence Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 About the NY MPJE Exam 1.2 Study Strategy & Federal vs. New York Law Hierarchy
2 Federal Pharmacy Law: Controlled Substances
2.1 Controlled Substances Act & DEA Scheduling 2.2 DEA Registration, Forms & Security 2.3 Federal Food, Drug, and Cosmetic Act (FDCA)
3 Federal Pharmacy Law: Privacy & Supply Chain
3.1 HIPAA & Patient Privacy 3.2 OBRA '90, Medicare/Medicaid & DUR 3.3 DSCSA & Drug Supply Chain Integrity
4 Area 1a: NYSED, Board & Pharmacist Licensure
4.1 NYSED Office of the Professions, Board of Pharmacy & Education Law Article 137 4.2 Pharmacist Licensure: Education, NAPLEX/MPJE & Internship 4.3 License by Endorsement, Renewal & Continuing Education
5 Area 1b: Interns, Technicians & Discipline
5.1 Pharmacy Interns & Limited Permits 5.2 Registered Pharmacy Technicians (RPhT) & Supervision Ratios 5.3 Professional Misconduct, Discipline & Impaired Practitioner Programs
6 Area 2a: Prescribing, Controlled Substances & Collaborative Practice
6.1 Prescription Requirements & Practitioner Authority 6.2 Controlled Substance Prescribing & the NY EPCS Mandate 6.3 Refills & Authority Limitations 6.4 Collaborative Drug Therapy Management (§6801-a) & Non-Patient-Specific Orders
7 Area 2b: Counseling, Immunization & Public Health
7.1 Patient Counseling & Documentation 7.2 Pharmacist Immunization Authority 7.3 Naloxone Access & Public Health Programs 7.4 Patient Confidentiality & Pharmacy Records
8 Area 3a: Verification, Transfers & DUR/I-STOP
8.1 Legitimate Medical Purpose & Corresponding Responsibility 8.2 Prescription Transfers Between Pharmacies 8.3 Prospective DUR & the I-STOP PMP Registry 8.4 Refill Exceptions & Emergency Dispensing
9 Area 3b: Labeling, Packaging & Substitution
9.1 Labeling of Dispensed Drugs 9.2 Packaging: PPPA & Child-Resistant Containers 9.3 Generic Substitution & Interchangeable Biologics (§6816-a) 9.4 OTC, Behind-the-Counter & Restricted Nonprescription Sales
10 Area 4a: Records, Inventories & Delivery
10.1 Ordering, Acquisition & Distribution Records 10.2 Recordkeeping, Storage & Handling 10.3 Controlled Substance Inventories & BNE Registration 10.4 Delivery & Mail-Order Dispensing
11 Area 4b: Compounding, Central Fill & Facilities
11.1 Compounding: Non-Sterile, Sterile & Hazardous Drugs 11.2 Central Fill, Centralized Processing & Shared Pharmacy Services 11.3 Automated Dispensing & Telepharmacy 11.4 Pharmacy Establishment Registration, Inspections & Discipline
12 Test-Day Strategy & Final Review
12.1 When New York Law Is Stricter Than Federal Law 12.2 Test-Day Strategy & Common Traps
5.3 Professional Misconduct, Discipline & Impaired Practitioner Programs
Key Takeaways Explain This Topic AI
Professional misconduct for New York pharmacists is defined centrally in Education Law § 6509 (14 subdivisions, including impaired practice, gross negligence/incompetence, and aiding unlicensed practice) plus 8 NYCRR Part 29 ("unprofessional conduct," 14 subdivisions covering confidentiality, fee-splitting, false reports, and more).
All licensed professions except physicians/PAs/specialist assistants (who go through DOH's Office of Professional Medical Conduct) are investigated and prosecuted by NYSED's Office of Professional Discipline (OPD); most investigations close within 9 months.
Penalties under Education Law § 6511 range from censure/reprimand through fines of up to $10,000 per specification, probation, suspension, and license revocation; the Board of Regents may stay part of a penalty or impose conditions.
Pharmacists are among the licensees covered by New York's mandatory reporting statute (Public Health Law § 230(11)(a), which applies to Education Law Article 137 licensees); facilities must separately report specified misconduct incidents within 30 days under Public Health Law § 2803-e.
New York's Professional Assistance Program (PAP), run by NYSED's Office of the Professions, lets impaired pharmacists voluntarily surrender their license during confidential treatment rather than face a misconduct charge, with a minimum 2-year post-reinstatement monitoring period.
Last updated: July 2026
What Counts as Professional Misconduct
Unlike states that route physician and pharmacist discipline through separate boards, New York defines professional misconduct for nearly all licensed professions — including pharmacy — through a shared statutory framework : Education Law § 6509 ("Definitions of professional misconduct") and Title 8 NYCRR Part 29 ("Unprofessional Conduct"), both administered by the New York State Education Department (NYSED).
Education Law § 6509 lists misconduct categories that apply across licensed professions, including:
Obtaining a license fraudulently .
Practicing fraudulently , beyond authorized scope , with gross incompetence , or with negligence/incompetence on more than one occasion .
Practicing while the ability to do so is impaired by alcohol, drugs, or physical or mental disability .
Being habitually drunk or dependent on narcotics, barbiturates, amphetamines, hallucinogens, or similar substances.
A prior criminal conviction , a prior professional misconduct finding in another jurisdiction, or discipline against a related license.
Discriminatory refusal of professional services based on race, creed, color, or national origin.
Permitting, aiding, or abetting an unlicensed person to perform activities requiring a license.
Practicing while suspended , or failing to register changes in name, address, or business status.
"Unprofessional conduct" as further defined by the Board of Regents or Commissioner — this is the bridge to Part 29.
8 NYCRR Part 29 then fills in the specifics of "unprofessional conduct" that § 6509(9) references, including: willful or grossly negligent failure to comply with governing law; exploiting patients for financial gain; fee-splitting and improper referral fees ; moral unfitness to practice; willfully filing false reports or impeding required filings; failing to provide patients copies of paid-for records; unauthorized disclosure of confidential information obtained in a professional capacity; performing services beyond authorized scope ; improperly delegating professional responsibilities to unqualified persons; performing unauthorized services ; false or deceptive advertising ; failing to respond within 30 days to Department communications; and violating probation conditions set by the Board of Regents.
A pharmacy-specific example that combines both frameworks: a pharmacist who lets an unregistered support employee perform RPhT-scope compounding without supervision violates § 6509(7) (aiding unlicensed practice) and potentially Part 29's scope-of-practice and delegation provisions simultaneously.
Who Investigates — The Office of Professional Discipline
For every licensed profession except physicians, physician assistants, and specialist assistants (whose conduct is handled by the Department of Health's Office of Professional Medical Conduct , OPMC), professional misconduct is investigated and prosecuted by NYSED's Office of Professional Discipline (OPD) , part of the broader Office of the Professions . Pharmacists and pharmacies fall squarely under OPD , not OPMC.
The OPD complaint and investigation pipeline generally runs:
Complaint intake — anyone (a patient, coworker, employer, or the Department itself) may file a complaint; the complainant does not need to prove misconduct occurred before filing.
Initial review — a supervising investigator logs the complaint and determines jurisdiction.
Investigation — a senior investigator gathers facts and conducts interviews, generally attempting to contact the complainant.
Screening decision — three parties jointly decide whether to bring charges: the assigned investigator, a prosecuting attorney, and a State Board member for the profession (for pharmacy, a member of the State Board of Pharmacy).
Prosecution and hearing — chargeable cases move to the Prosecutions Division; the most serious cases are ultimately reviewed and finally acted on by the Board of Regents .
Most investigations close within 9 months or less , though complex or contested cases can extend past two years.
Range of Sanctions (Education Law § 6511)
When the Board of Regents finds a licensee guilty of professional misconduct, Education Law § 6511 authorizes a graduated menu of penalties:
- Sanction Notes
- Censure and reprimand Least severe; a formal rebuke on the licensee's record
- Fine Up to $10,000 per specification (a case can carry multiple specifications, multiplying exposure)
- Probation Practice continues under monitored conditions
- Suspension Time-limited loss of practice authority
- Revocation Reserved for the most serious misconduct; permanent loss of the license
- Required education, training, or public service May be imposed alone or alongside another sanction
The Board of Regents may stay a penalty in whole or in part, effectively converting a suspension into a probationary period conditioned on compliance.
Mandatory Reporting Duties
New York imposes reporting obligations at two levels :
Individual licensee reporting — under Public Health Law § 230(11)(a) , mandatory reporting duties extend to licensed professionals under Education Law Articles 131, 131-B, 133, 137, and 139 . Article 137 is Pharmacy — meaning pharmacists are within the class of licensees this statute reaches for reporting purposes, alongside the medical and osteopathic societies and hospital leadership it also names.
Facility-level reporting — separately, Public Health Law § 2803-e requires hospitals and other Article 28 facilities to report, within 30 days , incidents such as the suspension, restriction, or termination of a licensee's privileges for alleged impairment, incompetence, or misconduct; a resignation made to avoid discipline; or a licensee's criminal conviction. Reports on non-physician licensees (including pharmacists working in covered facilities) go in writing to the Education Department . Good-faith reporting carries statutory immunity from civil or criminal liability , and good faith is legally presumed .
Practical takeaway for the exam: a pharmacist who becomes aware of a colleague's suspected impairment or misconduct is not simply free to look the other way — reporting channels exist and are backed by both a duty framework and liability protection for good-faith reporters.
New York's Impaired-Practitioner Program — the Professional Assistance Program (PAP)
New York's confidential, non-disciplinary pathway for impaired licensees is the Professional Assistance Program (PAP) , administered directly by NYSED's Office of the Professions (not a separate outside vendor). PAP allows a pharmacist with a substance-use problem — who has not harmed a patient or client — to address the impairment through treatment rather than a contested misconduct proceeding. Core eligibility conditions:
Complete abstinence from all mood-altering substances, including alcohol, during participation.
Temporary voluntary surrender of the professional license for the duration of active treatment.
Treatment at a PAP-approved agency.
Monitoring for at least two years after the license is reinstated, including toxicology reports, work-site reports, and random observed drug screens.
Applications are reviewed by a three-member panel of the Committee for Professional Assistance , joined by a State Board member for the applicant's profession; interviews are informal and confidential , and no transcript is made . Contact is through PAP directly (518-485-9380; pap@nysed.gov ), not through the OPD complaint process — this is a deliberately separate track from formal discipline.
Exam Scenario
A New York pharmacist self-identifies a developing opioid dependency after several months of diverting small quantities from pharmacy stock, but no patient has been shorted or harmed and no complaint has been filed. What is this pharmacist's most favorable path?
Self-referral to the Professional Assistance Program before any Board action begins: voluntary temporary license surrender, treatment at a PAP-approved agency, complete abstinence, and at least two years of post-reinstatement monitoring — avoiding the OPD investigation/prosecution track and its exposure to § 6511 penalties, including possible revocation. Note that PAP eligibility assumes no patient harm has occurred ; diversion that harmed a patient (e.g., dispensing errors caused by impairment) shifts the case toward OPD's disciplinary track regardless of self-reporting.